MYINX
Price
$8.15
Change
-$0.02 (-0.24%)
Updated
Feb 21 closing price
Net Assets
223.49M
VTSNX
Price
$134.80
Change
-$0.78 (-0.58%)
Updated
Feb 21 closing price
Net Assets
445.3B
Ad is loading...

MYINX vs VTSNX

Header iconMYINX vs VTSNX Comparison
Open Charts MYINX vs VTSNXBanner chart's image
NYLI WMC International Rsrch Eq Inv Cl
Price$8.15
Change-$0.02 (-0.24%)
VolumeN/A
Net Assets223.49M
Vanguard Total Intl Stock Index I
Price$134.80
Change-$0.78 (-0.58%)
VolumeN/A
Net Assets445.3B
MYINX vs VTSNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MYINX vs. VTSNX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MYINX is a Buy and VTSNX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VTSNX has more cash in the bank: 445B vs. MYINX (223M). VTSNX pays higher dividends than MYINX: VTSNX (3.29) vs MYINX (1.36). MYINX was incepted earlier than VTSNX: MYINX (17 years) vs VTSNX (14 years). MYINX has a lower initial minimum investment than VTSNX: MYINX (1000) vs VTSNX (5000000). MYINX annual gain was more profitable for investors over the last year : 12.91 vs. VTSNX (7.55). VTSNX (19.74) and MYINX (19.13) have equivalent 5 years return.
MYINXVTSNXMYINX / VTSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence17 years14 years-
Gain YTD7.2376.376113%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets223M445B0%
Annual Yield % from dividends1.363.2941%
Returns for 1 year12.917.55171%
Returns for 3 years13.455.99225%
Returns for 5 years19.1319.7497%
Returns for 10 years12.5732.9138%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTIS98.37-0.66
-0.67%
Otis Worldwide Corp
STEL28.64-0.30
-1.04%
Stellar Bancorp
GATX161.95-2.31
-1.41%
GATX Corp
RAVE2.56-0.05
-1.92%
Rave Restaurant Group
FHTX5.23-0.15
-2.79%
Foghorn Therapeutics